1. Home
  2. VYGR vs BCBP Comparison

VYGR vs BCBP Comparison

Compare VYGR & BCBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • BCBP
  • Stock Information
  • Founded
  • VYGR 2013
  • BCBP 2000
  • Country
  • VYGR United States
  • BCBP United States
  • Employees
  • VYGR N/A
  • BCBP N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • BCBP Savings Institutions
  • Sector
  • VYGR Health Care
  • BCBP Finance
  • Exchange
  • VYGR Nasdaq
  • BCBP Nasdaq
  • Market Cap
  • VYGR 164.3M
  • BCBP 143.5M
  • IPO Year
  • VYGR 2015
  • BCBP N/A
  • Fundamental
  • Price
  • VYGR $3.20
  • BCBP $9.15
  • Analyst Decision
  • VYGR Strong Buy
  • BCBP Hold
  • Analyst Count
  • VYGR 8
  • BCBP 2
  • Target Price
  • VYGR $14.33
  • BCBP $11.75
  • AVG Volume (30 Days)
  • VYGR 715.4K
  • BCBP 99.6K
  • Earning Date
  • VYGR 08-05-2025
  • BCBP 07-18-2025
  • Dividend Yield
  • VYGR N/A
  • BCBP 6.93%
  • EPS Growth
  • VYGR N/A
  • BCBP N/A
  • EPS
  • VYGR N/A
  • BCBP 0.15
  • Revenue
  • VYGR $66,958,000.00
  • BCBP $63,178,000.00
  • Revenue This Year
  • VYGR N/A
  • BCBP $22.41
  • Revenue Next Year
  • VYGR $78.88
  • BCBP $10.90
  • P/E Ratio
  • VYGR N/A
  • BCBP $61.65
  • Revenue Growth
  • VYGR N/A
  • BCBP N/A
  • 52 Week Low
  • VYGR $2.65
  • BCBP $7.54
  • 52 Week High
  • VYGR $9.55
  • BCBP $14.04
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 51.88
  • BCBP 75.13
  • Support Level
  • VYGR $2.83
  • BCBP $7.67
  • Resistance Level
  • VYGR $3.43
  • BCBP $8.36
  • Average True Range (ATR)
  • VYGR 0.19
  • BCBP 0.23
  • MACD
  • VYGR 0.01
  • BCBP 0.16
  • Stochastic Oscillator
  • VYGR 55.22
  • BCBP 99.41

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About BCBP BCB Bancorp Inc. (NJ)

BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.

Share on Social Networks: